Year Ref IgE Targets Prevalence of autoreactive IgE Association
to disease
activity Association
to total
IgE levels Association to same specificity autoreactive IgG levels Methods
1974 112 BMZ 25%(4/16) nd nd nd IF
1976 116 BMZ 50%(2/4) nd nd nd IF
1980 117 BMZ 60%(15/25) nd nd nd IF
1996 114 BP230 63%(12/19) POS nd nd RIA
1998 115 BMZ, BP230, BP180 BP180: 0% (0/39); BMZ or BP230: 46%(18/39) nd POS POS IF
2000 118 BP180 55%(10/18) POS nd POS IB, ELISA
2003 119 BP180 86%(26/30) POS nd nd IB
2005 120 BP180 80%(8/10) nd nd POS IB, BHRA
2008 122 BP180, BP230 BP180: 22%(8/37), BP230:22%(8/37) POS POS POS ELISA
2008 121 BP180, BP230 BP180:30%(20/67), BP230:67%(45/67) NEG POS NC ELISA
2009 123 BP180 89% (16/18) nd NC POS IB
2009 124 BP180 77%(33/43) POS nd POS ELISA, IB, IF
2011 125 BMZ 43%(3/7) nd nd POS IF
2013 126 BP180 61%(19/31) NC nd NC ISAC
2014 127 BP180 75% (36/48) POS POS POS ELISA
2015 128 BP180 73 % (27/37) NC NC nd ELISA
2015 129 BP180 24% (10/41) NC nd POS ELISA
2015 130 BP180, BP230 DIF: 18% (18/100); ELISA: 17%(3/18) NC nd nd IF, ELISA
2016 131 BP180, BP230 BP180: 71%(12/17), BP230: 76%(13/17) POS nd POS ELISA
2016 132 BP180 79% (61/77) POS nd POS ELISA
2017 133 BP180, BP230 BP180:58%(21/36), BP230: 50% (18/36) POS POS POS ELISA
2017 134 BP180 40% (47/117) POS POS POS ELISA
2020 135 BP180 DIF: 19%(10/53) NC NC POS IF, ELISA